174 related articles for article (PubMed ID: 18598229)
21. Cerebrospinal fluid analysis in multiple sclerosis.
Luque FA; Jaffe SL
Int Rev Neurobiol; 2007; 79():341-56. PubMed ID: 17531849
[TBL] [Abstract][Full Text] [Related]
22. Biobanks for biomarkers in neurological disorders: the Da Vinci bridge for optimal clinico-pathological connection.
Ravid R
J Neurol Sci; 2009 Aug; 283(1-2):119-26. PubMed ID: 19324376
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
[TBL] [Abstract][Full Text] [Related]
24. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
25. [Cerebrospinal fluid in neurodegenerative dementia pathologies].
Boucraut J; Desplat-Jego S; Duplan L; Verdier JM; Michel B; Bernard D
Ann Biol Clin (Paris); 2000; 58(3):361-6. PubMed ID: 10846242
[No Abstract] [Full Text] [Related]
26. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
27. Biobanking of CSF: international standardization to optimize biomarker development.
Teunissen CE; Tumani H; Engelborghs S; Mollenhauer B
Clin Biochem; 2014 Mar; 47(4-5):288-92. PubMed ID: 24389077
[TBL] [Abstract][Full Text] [Related]
28. CSF biomarkers in neurodegenerative diseases.
Mattsson N
Clin Chem Lab Med; 2011 Mar; 49(3):345-52. PubMed ID: 21303297
[TBL] [Abstract][Full Text] [Related]
29. Oxysterols as markers of neurological disease--a review.
Leoni V
Scand J Clin Lab Invest; 2009; 69(1):22-5. PubMed ID: 19199127
[TBL] [Abstract][Full Text] [Related]
30. NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration.
Brureau A; Blanchard-Bregeon V; Pech C; Hamon S; Chaillou P; Guillemot JC; Barneoud P; Bertrand P; Pradier L; Rooney T; Schussler N
Neurobiol Dis; 2017 Aug; 104():73-84. PubMed ID: 28392472
[TBL] [Abstract][Full Text] [Related]
31. The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research.
Kansal K; Irwin DJ
Psychiatr Clin North Am; 2015 Jun; 38(2):309-22. PubMed ID: 25998118
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in geriatric psychiatry: searching for the holy grail?
Blumberger DM; Daskalakis ZJ; Mulsant BH
Curr Opin Psychiatry; 2008 Nov; 21(6):533-9. PubMed ID: 18852558
[TBL] [Abstract][Full Text] [Related]
33. Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS.
Wuolikainen A; Hedenström M; Moritz T; Marklund SL; Antti H; Andersen PM
Amyotroph Lateral Scler; 2009 Aug; 10(4):229-36. PubMed ID: 19412814
[TBL] [Abstract][Full Text] [Related]
34. Highly selective artificial gel antibodies for detection and quantification of biomarkers in clinical samples. II. Albumin in body fluids of patients with neurological disorders.
Ghasemzadeh N; Nyberg F; Hjertén S
J Sep Sci; 2008 Dec; 31(22):3954-8. PubMed ID: 19065610
[TBL] [Abstract][Full Text] [Related]
35. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers of HIV related central nervous system disease.
Brew BJ; Letendre SL
Int Rev Psychiatry; 2008 Feb; 20(1):73-88. PubMed ID: 18240064
[TBL] [Abstract][Full Text] [Related]
37. Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion.
Sargin D; Hassouna I; Sperling S; Sirén AL; Ehrenreich H
Glia; 2009 May; 57(7):693-702. PubMed ID: 18985736
[TBL] [Abstract][Full Text] [Related]
38. Longstanding psychological stress in relation to biomarkers of neuronal dysfunction in cerebrospinal fluid: a 25-year follow-up study in women.
Johansson L; Sacuiu S; Kern S; Guo X; Zetterberg H; Blennow K; Zettergren A; Skoog I
Neurobiol Aging; 2019 Aug; 80():111-115. PubMed ID: 31128566
[TBL] [Abstract][Full Text] [Related]
39. Toward biomarkers in multiple sclerosis: new advances.
Lolli F; Rovero P; Chelli M; Papini AM
Expert Rev Neurother; 2006 May; 6(5):781-94. PubMed ID: 16734525
[TBL] [Abstract][Full Text] [Related]
40. Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples.
Greco V; Pieragostino D; Piras C; Aebersold R; Wiltfang J; Caltagirone C; Bernardini S; Urbani A
Proteomics; 2014 Sep; 14(17-18):1954-62. PubMed ID: 25044759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
